Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 1 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Exposome Pvt Ltd. is managing 2 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions involve 2 distinct examiners and are located within 1 distinct art unit. This suggests that while different individuals are reviewing the company's applications, they all belong to the same specialized administrative group. Such a structure allows for some consistency in the examination environment while still involving multiple perspectives from 2 distinct examiners.
MCCAIG, BRIAN A is the busiest examiner for the portfolio, overseeing 1 pending office action. With 2 distinct examiners for 2 pending actions, each examiner is currently handling a single active matter. This even distribution of the workload means that no single examiner is overwhelmed by the company's filings. For the practitioner, this indicates that each of the 2 pending office actions is receiving individual attention from different staff members within the same art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MCCAIG, BRIAN A | 1 | 80.4% | +13.3% |
| LEE, SIN J | 1 | 68.8% | +25.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18605322 | ADVANCED ANTIMICROBIAL AND CHEMICAL FILTERS FOR GAS AND WATER SYSTEMS | MCCAIG, BRIAN A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18413411 | DISINFECTANT COMPOSITION FOR INFUSION INTO POROUS SURFACES AND THE METHOD OF PREPARATION THEREOF | LEE, SIN J | 16d overdue |
| 18605322 | ADVANCED ANTIMICROBIAL AND CHEMICAL FILTERS FOR GAS AND WATER SYSTEMS | MCCAIG, BRIAN A | — |
| Art Unit | Apps |
|---|---|
| 1613 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18605322 | ADVANCED ANTIMICROBIAL AND CHEMICAL FILTERS FOR GAS AND WATER SYSTEMS | MCCAIG, BRIAN A | — | §103§112 | Non-Final OA | — | Pending | Mar 14, 2024 |
| 18413411 | DISINFECTANT COMPOSITION FOR INFUSION INTO POROUS SURFACES AND THE METHOD OF PREPARATION THEREOF | LEE, SIN J | 1613 | §103 | Non-Final OA | 16d overdue | Pending | Jan 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial